Typography by Sergi Delgado
Company Information
As of 3/29/23
Country
U.S.
Headquarters
New York City
Industry
Pharmaceuticals
CEO
Albert Bourla
Website
Company Type
Public
Ticker
PFE
Revenues ($M)
$100,330
Profits ($M)
$31,372
Market Value ($M)
$225,437
Employees
83,000
Figures are for fiscal year ended Dec. 31, 2022. Market value as of March 8, 2023. Sources: S&P Global; Bloomberg.
Key Financials (Last Fiscal Year)As of 8/3/2022
($ Millions)
% change
Revenues ($M)
$81,288
94%
Profits ($M)
$21,979
128.6%
Assets ($M)
$181,476
-
Total Stockholder Equity ($M)
$77,201
-
Profit RatiosAs of 8/3/2022
Profit as % of Revenues
27%
Profits as % of Assets
12.1%
Profits as % of Stockholder Equity
28.5%
Pfizer Rank History
Historical Data
| Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
|---|---|---|---|---|
| 2021 | $41,908-19% | $9,616-40.9% | $154,229 | $63,238 |
| 2020 | $51,750-3.5% | $16,27345.9% | $167,489 | $63,143 |
| 2019 | $53,6472.1% | $11,153-47.7% | $159,422 | $63,407 |
| 2018 | $52,546-0.5% | $21,308195.3% | $171,797 | $71,308 |
| 2017 | $52,8248.1% | $7,2153.7% | $171,615 | $59,544 |
SHOW MORE
Latest news for Pfizer
- Health
Pfizer is on the hunt for new blockbuster drugs, backed by its COVID fortuneNovember 8, 2022, 2:15 PM UTC - Europe
Europe’s drug regulator set to approve Moderna and Pfizer Omicron boosters this weekAugust 31, 2022, 4:09 PM UTC
- Novavax CEO on why his Covid vaccine is "demonstrably better" than Pfizer and Moderna;7:03Series, On Leading;
- Brainstorm Health 2022 - Burned Out: Tackling Well-Being And Mental Resilience In The Workplace;19:05Conferences, Brainstorm Health;
- Brainstorm Health 2022 - Leveraging New Frontiers: The Importance Of A Global Strategy ;21:29Conferences, Brainstorm Health;
- FDA recommends second booster for ages 50 and older;1:28News, Raw;
